April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 23, 2025

Life's Essential 8 Helps Predict CVD

"Greater cumulative CVH and improvement in CVH during young adulthood, as well as better CVH in middle age, were all independently associated with lower risk for incident CVD in midlife."

Conexiant

April 22, 2025

Dual Therapy Lowers Death Risk in Diabetes Study

A large study found that combining GLP-1 receptor agonists with thiazolidinediones significantly reduced death and heart risks in patients with type 2 diabetes.

Conexiant

April 21, 2025

Risk-Free Midlife: 10+ Years Longer Living

Prioritizing the prevention and treatment of the modifiable risk factors could substantially extend healthy life expectancy worldwide.

Conexiant

April 17, 2025

Early Ezetimibe After MI Tied to Reduced MACE in SWEDEHEART Registry

Delaying ezetimibe use after MI was associated with worse outcomes in a Swedish national cohort study of 35,826 patients.

Conexiant

April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant

April 15, 2025

Mavacamten Misses Endpoints in nHCM Trial

Mavacamten's phase III trial for nonobstructive hypertrophic cardiomyopathy does not show significant improvement in functional capacity or symptoms, reflecting challenges in less severe populations. Bristol Myers Squibb plans to present full data at a future scientific meeting.

Reuters

April 15, 2025

Tenecteplase Matches Alteplase in Stroke Outcomes

In a registry-based study of 79,550 patients, tenecteplase showed comparable short-term safety and effectiveness to alteplase for acute ischemic stroke, with no significant differences in functional outcomes or hemorrhagic events.

Conexiant

April 14, 2025

Pecans May Lower Cholesterol, Triglycerides

Replacing usual snacks with 57 g/d of pecans for 12 weeks improved lipids and diet quality.

Conexiant